Pursuant to 42 CFR 423.568(e) and (f),
if a Part D plan denies drug coverage it must give the enrollee
written notice of the adverse coverage determination. The form and
content of the written denial notice must comport with specific
requirements, including a description of the appeals
process.
The Part D denial notice has
been revised for clarity and includes new language explaining to
the enrollee that the notice should be shared with his/her doctor.
A Crosswalk of the changes to the notice and the instructions is
included with this package. None of the changes impact our
currently approved burden estimates. There is an increase to the
total hourly burden estimate for this collection. When this
information collection was approved in February 2014, the estimate
for the burden hours was 374,482 hours. The estimated annual hour
burden for this package is now 475,514 (+101,032). Since the last
collection was approved, there has been a slight decrease in the
number of Part D plan sponsors used to estimate the burden, from
596 to 580 (-16), but the estimate for the total number of denial
notices that will be issued across Part D plan sponsors has
increased by 404,126 (to a total estimate of 1,902,055) and is
based on the most recently validated Part D plan sponsor reported
data (2014).
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.